Health care cost analysis of enhanced pacing modalities in bradycardia patients: Portuguese case study on the results of the MINERVA trial João de Sousa, Pedro Marques, Vítor Martins, António Hipólito-Reis, Luís Duarte, Inês Joaquim, Diogo Monteiro, Giuseppe Boriani, Claudia Wolff, Andrea Grammatico, Luigi Padeletti

Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting João Morais, Carlos Aguiar, Euan McLeod, Ismini Chatzitheofilou, Isabel Fonseca Santos, Sónia Pereira

Enhanced pacing modalities in bradycardia patients: Can technology reduce costs? Mário Martins Oliveira